The Requirements of Non-Toxic PVC Compounds for Medical Applications
Compliance with Standards
PVC compounds intended for medical applications should comply with the
specifications laid down in the National Pharmacopoeia of the country where it
is manufactured and also the Pharmacopoeial requirements of the countries where
it is marked as given below:
Country/Region Compliance
|
India
Japan
Europe
Great Britain
America |
- Indian Pharmacopoeia
- Japanese Pharmacopoeia
- European Pharmacopoeia
- British Pharmacopoeia
- US Pharmacopoeia |
These standards require that the PVC material should comply
with stringent physical, chemical and non toxicity requirements. To meet these
criteria, utmost care has to be exercised in the selection of raw materials
used. All additives used must be of high purity to meet the specific end use
requirements. The US FDA has an approved list of additives for use in food and
drug applications. The European Pharmacopoeia has specified additives to be used
for blood bag applications.
In addition, low toxicity of PVC materials are required to be
assured by conducting a series of suitable biological tests.
Pharmaceutical Requirements for Medical Grade PVC Materials
The requirements for medical grade PVC in Pharmacopoeias are
discussed below:
The European Pharmacopoeia
The European Pharmacopoeia is quite comprehensive. It has defined the
plasticisers, stabilisers, lubricants and other additives to be used for making
non toxic PVC to be used for blood bags and for intravenous fluids. Compliance
requirements for PVC materials, extracts prepared therefrom, physical,
physico-chemical and biological tests to be done on container material are
clearly specified. Sub section 3.1 has laid down requirements for containers and
tubings respectively as follows:
Sub section 3.1.1 :
Materials based on plasticised poly vinyl chloride for
containers for human blood and blood components and for aqueous solutions for
intravenous infusion.
Sub section 3.1.2 :
Materials based on plasticised poly vinyl chloride for tubing
used in sets for the transfusion of blood and blood components.
Containers for blood and blood components are discussed under
four sub sections viz.
3.2.3 Sterile plastic containers for human blood and blood
components.
3.2.4 Empty sterile containers of plasticized poly vinyl
chloride for human blood and blood components.
3.2.5 Sterile containers of plasticized poly vinyl chloride
for human blood containing an anticoagulant solution.
3.2.6 Sets for the transfusion of blood and blood
components.
The only biological test required to be done is Abnormal
toxicity which is systemic injection test using normal saline extract of the PVC
material and mice as test animals.
The British Pharmacopoeia
The specifications of European Pharmacopoeia for plastic containers are
incorporated in edited form in Appendices XIXE and XIFF of the British
Pharmacopoeia. The Appendices provide guidance for users of plastic containers
and the statements made therein are not mandatory.
Appendix XIXF relates to containers for blood and blood
components and is discussed under three sub sections as in the European
Pharmacopoeia.
The United States Pharmacopoeia
The US Pharmacopoeia requires that plastic materials for
medical applications should in addition to tests on plastic material and on
extracts prepared therefrom under specified conditions, also meet the
requirements of three in vitro biological tests on the material or extracts
prepared therefrom.
These tests are designed to assess the biological reactivity
(cellular degeneration and mal formation) of mammalian fibro plast cell cultures
in contact with the test material. The in vitro tests are :
-
Agar diffusion test
-
Direct contact test
-
Elution test
Materials that meet the requirements of the in vitro tests
are not required to undergo further testing. Materials that do not pass the in
vitro tests are not suitable for containers for drug products.
| Table-2
: Classification of Plastics (USP) |
| Plastic Classesa |
Tests to be Conducted |
|
I II III IV V VI |
Test Material |
Animal |
Dose |
Procedureb |
|
X X X X
X X
X X X X
X X |
Extract of sample in
Sodium Chloride Injection |
Mouse
Rabbit
|
50ml / kg 0.2 animal at each of 10 sites |
A(iV)
B |
|
X X
X X X
X X
X X X |
Extract of sample in 1 in 20
Solution of Alcohol in Sodium Chloride Injection |
Mouse
Rabbit |
50ml / kg 0.2 animal at each of 10 sites |
A(iV)
B |
|
X X X
X X |
Extract of sample in
Polyethylene Glycol
400
|
Mouse
Rabbit |
50ml / kg 0.2 animal at each of 10 sites |
A(iP)
B |
|
X X X X
X X X |
Extract of sample in vegetable oil |
Mouse
Rabbit |
50ml / kg 0.2 animal at each of 10 sites |
A(iP)
B |
|
X X |
Implant strips of sample |
Rabbit |
4 strips/animal |
C |
|
a Tests required for each class are
indicated by ‘X’ in appropriate columns
b Legend: A(ip)-Systemic Injection Test
(intraperitoneal); A(iv)-Systemic Injection Test (intravenous);
B-Intracutaneous Test (intracutaneous);
C-Implantation Test (intramuscular implantation) |
The USP has classified plastics into six plastic classes
based on responses to three in vivo biological tests (Table-2).
-
Systemic injection test
-
Intracutaneous test
-
Implantation test
These three tests are applied to materials or medical devices
if there is a need for classification of plastics based on in vivo biological
reactivity testing.
The systemic injection test and the intracutaneous test are used for
elastomeric material especially where biological reactivity tests in vitro have
indicated significant biological reactivity. These two tests in addition to
implantation test are applied for plastics and other polymers used for
fabricating containers and accessories thereto for parenterals, and for use in
medical devices, implants and other systems.
The Indian Pharmacopoeia
Physical, chemical and biological tests are described for
plastic containers in which pharmaceutical preparations are dispensed.
Physical and chemical tests comprise tests on containers and
container material to assess permeability, toxicity and heavy metal content.
Physico chemical tests are done on water extracts of the plastic material as
described earlier under USP requirements.
Recommended biological tests are:
Systemic injection test on mice and intracutaneous test on
albino rabbits using the four extracts given below:
-
Sodium chloride injection
-
5% solution of ethanol in sodium chloride injection
-
Polyethylene glycol 400 and
-
Vegetable oil
Standards for Polyvinyl Chloride Containers for Collection and Storage of
Blood and Blood Components
International Standard ISO - 3826
This is a comprehensive standard and covers all aspects of the design and
testing of containers of plasticised PVC comprising physical, physico chemical
and biological test protocols, requirements and testing of labels, cannulae and
packaging.
Non toxicity of the PVC material is of utmost importance and
assessments are to be based on the basis of a series of suitable tests as
described below :
-
Pyrogenicity
-
Haemolysis test
-
Systemic injection test
-
Intracutaneous test
-
Cytotoxicity and
-
Sensitation test
|